Physician profile
Hazel E Bowen Wright
NPI 1750380887
$4,180.09
in general payments reported to CMS, 2019-2025
35 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $200 · 2022: $180 · 2023: $657 · 2024: $904 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767 · Education: $44.05 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.36 |
| Education | $44.05 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $815.05 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $383.36 | 2019-2025 | |
| Novo Nordisk INC | $307.89 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Insulet Corporation | $251.06 | 2019-2025 | Omnipod, Omnipod |
| Amgen INC. | $249.26 | 2019-2025 | Evenity, Prolia, Tepezza |
| Abbvie INC. | $209.76 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $203.88 | 2019-2025 | Unithroid |
| Beta Bionics, INC. | $201.90 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $197.39 | 2019-2025 | Tymlos |
| Shire North American Group INC | $141.28 | 2019 | |
| Xeris Pharmaceuticals, INC. | $116.25 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Ibsa Pharma INC. | $110.76 | 2023-2025 | Licart, Tirosint, Tirosint |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.14 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $96.35 | 2022 | |
| Dexcom, INC. | $95.76 | 2019-2025 | Dexcom G6 Transmitter |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $82.60 | 2024-2025 | |
| Horizon Therapeutics Plc | $68.96 | 2019-2020 | |
| Acella Pharmaceuticals, LLC | $66.59 | 2023 | NP Thyroid 60 |
| Tandem Diabetes Care, INC. | $65.72 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ultragenyx Pharmaceutical INC. | $47.31 | 2023 | |
| Corcept Therapeutics | $42.71 | 2019-2025 | Korlym |
| Astrazeneca Pharmaceuticals Lp | $40.64 | 2019 | |
| Abbott Laboratories | $33.02 | 2022-2024 | Freestyle Insulinx |
| Soleno Therapeutics, INC. | $32.45 | 2025 | Vykat Xr |
| Ascendis Pharma Endocrinology INC | $24.79 | 2025 | Yorvipath |
| Madrigal Pharmaceuticals | $24.38 | 2025 | Rezdiffra |
| Amarin Pharma, INC. | $23.00 | 2019 | |
| Mannkind Corporation | $22.28 | 2025 | |
| Medtronic, INC. | $21.72 | 2023 | Minimed 780g |
| Pfizer INC. | $19.43 | 2019 | |
| Merck Sharp & Dohme LLC | $17.74 | 2019 | |
| Kyowa Kirin, INC. | $17.39 | 2025 | |
| Valeritas, INC. | $16.09 | 2019 | |
| Currax Pharmaceuticals LLC | $15.09 | 2024 | Contrave |
| Janssen Pharmaceuticals, INC | $15.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hazel Bowen Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.